Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5205323 | 6124767 | F | 4 | 5205323-4 | 20060718 | 20061215 | 20070108 | EXP | 228937 | GENENTECH, INC. | 49 | YR | F | N | 83 | KG | 20070105 | MD | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5205323 | 1008030461 | PS | AVASTIN | 1 | INTRAVENOUS | 415 MG, INTRAVNEOUS | Y | D | |||
| 5205323 | 1008062442 | C | IRINOTECAN HCL | 1 | |||||||
| 5205323 | 1008062443 | C | FOLINIC ACID (LECOVORIN CALCIUM) | 2 | |||||||
| 5205323 | 1008062444 | C | FLUOROURACIL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5205323 | 1008030461 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5205323 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5205323 | ALANINE AMINOTRANSFERASE INCREASED |
| 5205323 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 5205323 | BLOOD BILIRUBIN INCREASED |
| 5205323 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
| 5205323 | JAUNDICE |
| 5205323 | NEUTROPENIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5205323 | FGN |
| 5205323 | HP |
| 5205323 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5205323 | 1008030461 | 20060502 | 20060718 |